Roger Stupp, a Swiss neuro-oncologist, was named associate director for strategic initiatives at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Arti Hurria, City of Hope's new vice provost, plans to focus on faculty growth and development, including fostering faculty career development and ensuring more diverse voices are represented.
Gwen Nichols was named chief medical officer of the Leukemia & Lymphoma Society.
David Penson was named chair of the Science & Quality Council at the American Urological Association. He will assume the role of chair-elect on June 1 and begin his two-year term as chair on June 2018.
NCI awarded ATCC a five-year indefinite-delivery/indefinite-quantity contract to support the Division of Cancer Epidemiology and Genetics' Molecular Epidemiology Assay Support program.
The International Labour Organization voted on Wednesday to delay the decision on whether to cut ties with Big Tobacco until November.
Thomas Lynch was named chief scientific officer at Bristol-Myers Squibb.
The NCCN Oncology Research Program has awarded grants for its first-ever multi-industry collaborative project, soliciting investigator-initiated proposals to research the effectiveness of Boehringer Ingelheim's afatinib in combination with other drugs to treat lung and head and neck cancers.
By the time its annual conference concludes on March 25, the National Comprehensive Cancer Network aims to have 100 medical centers and practices that deliver chemotherapy committed to Just Bag It: The NCCN Campaign for Safe Vincristine Handling.
European Society For Medical Oncology said it will take over the organization of the Targeted Anticancer Therapies Congress, with the aim of expanding its educational offer and ensure that professionals are kept up-to-date with the latest drug developments to improve outcomes for cancer patients.
